Migranal

Product manufactured by Bausch Health Us, Llc

Application Nr Approved Date Route Status External Links
NDA020148 None Nasal None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage Migranal ® (Dihydroergotamine Mesylate) Nasal Spray Is Indicated For The Acute Treatment Of Migraine Headaches With Or Without Aura. Migranal ® (Dihydroergotamine Mesylate) Nasal Spray Is Not Intended For The Prophylactic Therapy Of Migraine Or For The Management Of Hemiplegic Or Basilar Migraine.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Dihydroergotamine Mesylate DIHYDROERGOTAMINE MESYLATE ZINC3978005

Comments